Smoking cessation drugs are de-addiction drugs for smoking. The alkaloid compound called nicotine causes addictive dependency on cigarettes and other smoking products. Smoking cessation results in withdrawal symptoms such as anxiety, strong cravings, depressing mood, insomnia and mood alterations.
This report contains market size and forecasts of Medications for Smoking Cessation in Global, including the following market information:
Global Medications for Smoking Cessation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Medications for Smoking Cessation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non Nicotine Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medications for Smoking Cessation include Nicotek, Cipla, GlaxoSmithKline, Dr Reddy's Laboratories, Johnson & Johnson, Fontem Ventures, Pfizer, NovartisNjoy Inc and Perrigo and Reynolds American Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medications for Smoking Cessation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medications for Smoking Cessation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medications for Smoking Cessation Market Segment Percentages, by Type, 2021 (%)
Non Nicotine Drugs
Nicotine Replacement Therapy (NRT)
Global Medications for Smoking Cessation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medications for Smoking Cessation Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies
Global Medications for Smoking Cessation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medications for Smoking Cessation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medications for Smoking Cessation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Medications for Smoking Cessation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nicotek
Cipla
GlaxoSmithKline
Dr Reddy's Laboratories
Johnson & Johnson
Fontem Ventures
Pfizer
NovartisNjoy Inc
Perrigo and Reynolds American Inc.